Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China. Issue 3 (29th November 2017)

• Record Type: Journal Article
• Authors: Wen, X.; Su, H.; Wang, Y.; Pu, Z.; Gao, J.; Ji, Z.; Yuan, X.; Li, X.; Zhang, W.; Zhang, L.; Long, Y.; Yan, Y.; Shao, Z.
• Is Part Of: Journal of viral hepatitis. Volume 25:Issue 3(2018)
• Page Start: 281
• Page End: 288
• Publication Date: 2017-11-29
• Subjects: community -- follow‐up -- mutation -- occult hepatitis B virus infection -- prevalence; Hepatitis, Viral -- Periodicals; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; 616.3623
• DOI: 10.1111/jvh.12805
• Languages: English
• ISSNs: 1352-0504

Abstract

Summary: Occult hepatitis B infection (OBI) is characterized by serum hepatitis B surface antigen (HBsAg) negative and hepatitis B virus (HBV) DNA positive (HBsAg‐/HBV DNA+). Occult hepatitis B infection in community‐based populations has been scarcely investigated, and OBI outcomes remain unclear, especially in Wuwei, a region located in Northwest China. This region is one of the areas in China that has the highest prevalence of chronic HBV infection. A prospective study was performed in the general population of 2 towns of Wuwei from June 2011 to May 2014. A questionnaire was used to collect demographic and medical data, and serum samples were collected from the participants and stored until analysis. DNA was detected using quantitative PCR (qPCR) or nested PCR, the HBV DNA from HBV DNA‐positive or possible positive (below the detection limit) subjects was extracted and amplified by nested PCR, and the PCR products were sequenced. Sequence analysis was performed using the Mega 6.0 program and CLC sequence viewer software. Hepatitis B virus DNA was detected in 90 of 3, 080 HBsAg‐negative subjects, and the prevalence of OBI in the study population was 2.92% (90/3, 080, 95% CI: 2.33%‐3.51%). Hepatitis B virus genomes in 51 of 80 objects (63.75%) contained mutations in the "a" determinant of HBsAg. After 2 years follow‐up, 42 of 90 HBV DNA of OBI subjects remained positive, and the natural clearance rate of OBI subjects was 53.3%. Occult hepatitis B infection prevalence in this cohort was much lower than chronic HBV infection in the same region. HBV DNA was cleared in most OBI subjects during the 2 year period. Our data suggest that some OBI may represent a late stage of resolving the HBV infection process.